Back to Search
Start Over
Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
- Source :
-
The Journal of experimental medicine [J Exp Med] 1995 Jun 01; Vol. 181 (6), pp. 2181-6. - Publication Year :
- 1995
-
Abstract
- Molecules representative of different classes of chemotactic agents, including formyl-Met-Leu-Phe (FMLP), C5a, leukotriene B4, platelet-activating factor, and interleukin (IL)-8, caused a rapid reduction in the IL-1 binding capacity by human polymorphonuclear leukocytes (PMN), a cell type expressing predominantly the IL-1 type II decoy receptor (IL-1 decoy RII). N-t-Boc-Met-Leu-Phe, an antagonist for the FMLP receptor, inhibited the loss of IL-1 binding capacity induced by FMLP. Monocyte chemotactic protein 1, a chemokine related to IL-8 but inactive on PMN, had no effect on IL-1 binding in this cell type. FMLP was selected for further detailed analysis of chemoattractant-induced loss of IL-1 binding by PMN. The action of FMLP was rapid, reaching 50% of its maximum (80%) at 30 s, the earliest measurable time point, and plateauing between 10 and 30 min. Dose-response analysis revealed that maximal reduction of IL-1 binding was reached at FMLP concentrations that were also optimal for chemotaxis (50% effective dose = 5 x 10(-9) M). The loss of IL-1 binding capacity caused by FMLP was determined by a reduction in receptor number with no change in their affinity. The effect of FMLP on IL-1 receptor (IL-1R) was selective in that the PMN surface structures IL-8R, CD16, CD18, and major histocompatibility complex class I antigens were unaffected under these conditions. Loss of surface IL-1R was not due to an augumented rate of internalization. FMLP caused rapid release of a 45-kD IL-1-binding molecule identified as the IL-1 decoy RII. After FMLP-induced release, PMN reexpressed newly synthesized receptors, reaching basal levels by 4 h. FMLP-induced release of the IL-1 decoy RII did not impair the responsiveness of PMN to IL-1 in terms of promotion of survival and cytokine production. FMLP-induced release of the IL-1 decoy RII was unaffected by protein synthesis inhibitors, was blocked by certain protease inhibitors, and was mimicked by agents (the Ca++ ionophore A23187 and phorbol myristate acetate) that recapitulate elements in the signal transduction pathway of chemoattractant receptors. The time frame and concentration range of chemoattractant-induced rapid release of the IL-1 decoy RII are consistent with the view that IL-1 decoy RII release is an early event in the multistep process of leukocyte recruitment.(ABSTRACT TRUNCATED AT 400 WORDS)
- Subjects :
- Amino Acid Sequence
Calcimycin pharmacology
Chemotaxis, Leukocyte drug effects
Complement C5a pharmacology
Humans
In Vitro Techniques
Interleukin-1 metabolism
Interleukin-1 pharmacology
Interleukin-8 pharmacology
Leukotriene B4 pharmacology
Molecular Sequence Data
N-Formylmethionine Leucyl-Phenylalanine pharmacology
Neutrophils drug effects
Neutrophils immunology
Oligopeptides pharmacology
Platelet Activating Factor pharmacology
Receptors, Interleukin-1 antagonists & inhibitors
Recombinant Proteins metabolism
Recombinant Proteins pharmacology
Tetradecanoylphorbol Acetate pharmacology
Chemotactic Factors pharmacology
Chemotaxis, Leukocyte physiology
Neutrophils physiology
Receptors, Interleukin-1 biosynthesis
Subjects
Details
- Language :
- English
- ISSN :
- 0022-1007
- Volume :
- 181
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- The Journal of experimental medicine
- Publication Type :
- Academic Journal
- Accession number :
- 7760005
- Full Text :
- https://doi.org/10.1084/jem.181.6.2181